Lung Cancer Trial, Not Yet Recruiting NCT07279948 Sponsor: AstraZeneca Condition: Lung Cancer
Back to Lung Cancer

Lung Cancer Trial, Not Yet Recruiting

NCT07279948
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 50 and 80 years old.
  • People who currently smoke, or who stopped smoking within the last 15 years.
  • People who have taken part in, or are currently taking part in, a program to help them stop smoking.
  • People who have a lifetime smoking history of at least 20 pack-years (a measure of how much a person has smoked over their lifetime — confirm with trial site if unsure how this is calculated).
  • People who have signed a consent form agreeing to take part in the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are claustrophobic or who weigh more than 130 kg, as these factors may prevent them from having the required screening examination.
  • People who are unable to climb 3 flights of stairs (36 steps) without stopping.
  • People who experience severely limiting breathlessness.
  • People who have symptoms that may suggest lung or breast cancer, including: chest pain that worsens with breathing; rapidly worsening breathlessness that started recently; coughing up blood; unexplained hoarseness lasting more than one month; bone pain; persistent swollen lymph nodes in the neck or above the collarbone; or unexplained weight loss of 5% or more of body weight in less than 6 months.
  • People who have been diagnosed with a cancer other than non-melanoma skin cancer within the last 10 years.
  • People who have been diagnosed with a severe psychiatric illness.
  • People whose immune system is weakened, either due to illness or medication.
  • People who have previously had part of a lung surgically removed, for any reason.
  • People who have a serious terminal illness that would make curative lung surgery unsuitable.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

If this is close to home

This page includes language about advanced illness, prognosis, or palliative care, because that is how the trial's eligibility criteria are written. Seeing it set out plainly can land hard, whether it is about you or about someone you are caring for. You do not have to be at a crisis point to talk to someone.

  • Griefline — grief and loss counselling, 9am to 6pm weekdays and midday to 6pm weekends (AEST/AEDT): 1300 845 745
  • Carer Gateway — practical and emotional support if you are caring for someone, 8am to 5pm weekdays: 1800 422 737
  • Canteen — for 12 to 25 year olds affected by cancer, their own or a family member's: 1800 945 215
  • Palliative Care Australia — directory of palliative care services near you: palliativecare.org.au
  • Lifeline — 24/7, for any kind of distress, at any hour the services above are closed: 13 11 14

Palliative care is not the same as giving up on treatment, and it is not only for the last weeks of life. It is symptom and comfort care that can run alongside active treatment, including a clinical trial.

Outside Australia? The numbers above are Australian and will not work from overseas. Find a Helpline is a free directory of support and crisis lines in over 130 countries, run by ThroughLine with the International Association for Suicide Prevention.

Voxsanity is not a counselling or medical service, and nothing on this page is medical advice. More Australian services are listed on our support lines page.

Contact this trial

Principal Investigator: Arn Migowski Rocha dos Santos, Instituto Nacional de Câncer

Phone: 1-877-240-9479

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Registry
ClinicalTrials.gov
Start date
30 June 2026
Est. completion
31 January 2027

Where this trial is recruiting

🇧🇷 Brazil

Primary endpoints

• Proportion of negative cases on screening according to the Lung-RADS classification.; • Proportion of false-positives.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov